Similar Articles
51 Donor hepatectomy time and liver transplantation outcomes: An opportunity that cannot be dismissed
52 Management of cytomegalovirus infection after liver transplantation
53 Statin, aspirin and metformin use and risk of hepatocellular carcinoma related outcomes following liver transplantation: A retrospective study
54 SIMAP500: A novel risk score to identify recipients at higher risk of hepatocellular carcinoma recurrence following liver transplantation
55 Genitourinary tumors and liver transplantation: A comprehensive review
56 Challenges related to clinical decision-making in hepatocellular carcinoma recurrence post-liver transplantation: Is there a hope?
57 Central nervous injury risk factors after endovascular repair of a thoracic aortic aneurysm with type B aortic dissection
58 Risk factors for secondary infection after liver failure and effect of comprehensive nursing intervention
59 Colon signet-ring cell carcinoma with chylous ascites caused by immunosuppressants following liver transplantation: A case report
60 Risk factors for intensive-care-unit-acquired weakness
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA